Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Viruses|September 9, 2014
Fiber-modified adenovirus for central nervous system Parkinson's disease gene therapyTravis B Lewis, Joel N Glasgow, Ashley S Harms, et al.
Neurochemical Research|August 25, 2001
Transcriptional regulation of the BCL-X gene by NF-kappaB is an element of hypoxic responses in the rat brainJ N Glasgow, J Qiu, D Rassin, et al.
Plos One|February 6, 2013
An adenovirus vector incorporating carbohydrate binding domains utilizes glycans for gene transferJulius W Kim, Joel N Glasgow, Masaharu Nakayama, et al.
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 20, 2009
Crystallization of the head and galectin-like domains of porcine adenovirus isolate NADC-1 fibrePablo Guardado-Calvo, Antonio L Llamas-Saiz, Gavin C Fox, et al.
Virology|June 9, 2004
An adenovirus vector with a chimeric fiber derived from canine adenovirus type 2 displays novel tropismJoel N Glasgow, Eric J Kremer, Akseli Hemminki, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 1, 2001
The relationship between low level nitrogen dioxide exposure and child lung function after cold air challengeA L Ponsonby, N Glasgow, P Gatenby, et al.
Biochemical and Biophysical Research Communications|August 3, 2005
Reovirus sigma1 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathwayYuko Tsuruta, Larisa Pereboeva, Joel N Glasgow, et al.
The Open Gene Therapy Journal|October 17, 2009
Enhanced Gene Delivery to Human Primary Endothelial Cells Using Tropism-Modified Adenovirus VectorsMeredith A Preuss, Joel N Glasgow, Maaike Everts, et al.
Journal of Virology|January 19, 2007
Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacyMatthieu Perreau, Franck Mennechet, Nicolas Serratrice, et al.
Molecular Cancer Therapeutics|December 20, 2002
A model system for the design of armed replicating adenoviruses using p53 as a candidate transgeneYosef S Haviv, Koichi Takayama, Joel N Glasgow, et al.
Pageof 6